hydrogen, potassium-adenosine triphosphatase; stria vascularis; spiral ligament THE COCHLEA OF THE INTERNAL EAR is a peripheral organ that amplifies and transforms the sound-derived mechanical signal to an electrical one, which will be transmitted to the brain. This transformation is performed in the cochlear hair cells, the primary receptor for hearing. The hair cells are bathed in two distinct types of extracellular fluid: perilymph and endolymph. The ionic composition of perilymph is identical to that of ordinary extracellular solution. On the other hand, endolymph contains 150 mM K ϩ , 2 mM Na ϩ , and 20 M Ca 2ϩ and has surprisingly high potential with reference to the body fluid of approximately ϩ80 mV, which is known as the endocochlear potential (EP) (86, 87) . While the basolateral side of a hair cell is bathed in perilymph, its apical membrane, which harbors the hair bundles, is exposed to endolymph. The sound-driven vibration of the basilar membrane deflects the hair bundles and opens mechanosensitive channels at the top of their cilia, which results in influx of K ϩ to the hair cells and thus their depolarization (30) . By forming a large driving force for K ϩ influx, EP directly contributes to the high sensitivity of the hair cells to mechanical stimulation.
It is assumed that K ϩ circulation from perilymph to endolymph through the cochlear lateral wall is essential to establish the high K ϩ concentration ([K ϩ ]) in endolymph and EP (90) . The lateral wall is divided into two components, 1) the spiral ligament, a connective tissue comprising several types of fibrocytes, and 2) the stria vascularis, an epithelial tissue containing marginal, intermediate, and basal cells. K ϩ secreted from the hair cells is transported to the endolymphatic space via the epithelium on the basilar membrane, the spiral ligament, and the stria vascularis. Whereas most of this K ϩ transport pathway is connected with gap junctions (10, 13, 35, 79) , the steps between the hair cells and the epithelium, between the epithelium and the spiral ligament, and between the basal cells and the marginal cells in the stria vascularis are not. At each step, K ϩ should be secreted from the former and absorbed by the latter. Finally, the marginal cells in the stria vascularis unidirectionally carry K ϩ from the intrastrial space to the endolymphatic space, the scala media (37, 81, 83) . Several K ϩ transport apparatuses, including Na
Ϫ cotransporter (NKCC1), and K ϩ channels (KCNQ1/KCNE1 and Kir4.1), have been identified expressed in the spiral ligament and/or stria vascularis. They are thought to play pivotal roles in cochlear K ϩ circulation, because application of specific inhibitors for each apparatus reduced EP (24, 43, 47, 48) and targeted ablation of the genes for NKCC1 and the K ϩ channels collapsed scala media (54, 81, 84) . The K ϩ channel Kir5.1, expressed in the fibrocytes in the lower part of the ligament, may negatively regulate K ϩ circulation and may be important for precise control of K ϩ flow (23) . It was recently reported that the gastric type H ϩ ,K ϩ -ATPase is expressed in the cochlear lateral wall (49) , but its details have not been studied. In this study, we have examined the precise cellular and subcellular localization of the H ϩ ,K ϩ -ATPase in the cochlea and its functional role in EP formation. Using RT-PCR analysis, we found the expression of gastric ␣ 1 -and accessory ␤-subunits, but not of the colonic ␣ 2 -subunit, in cochlea. The ␣ 1 -subunit was specifically localized in particular types of fibrocytes in the lateral wall and the limbus, as well as at the basolateral site of marginal cells. Both perilymphatic and vascular perfusion of Sch-28080, a specific inhibitor of the gastric H ϩ ,K ϩ -ATPase, suppressed EP. The unique distribution pattern and the pharmacological observations strongly suggest that the gastric-type H ϩ ,K ϩ -ATPase plays a crucial role in cochlear K ϩ circulation and thus in generation of the EP.
MATERIALS AND METHODS

Animals.
The experimental protocol of this study was carefully reviewed and approved by the Animal Research Committee of Osaka University Medical School. All the experiments were carried out under the supervision of the committee and in accordance with Guidelines for Animal Experiments of Osaka University and the Japanese Animal Protection and Management Law. The animals were fed and allowed water freely until they were used for the experiments.
RT-PCR. Adult male C57 Black6 mice (ϳ8 -10 wk old) were deeply anesthetized with pentobarbital sodium (50 mg/kg). Total RNA was extracted from their whole cochlea, kidney, and distal colon with TRIzol reagent in accordance with the manufacturer's protocol (Invitrogen, Carlsbad, CA). DNase I was added to each 5 g of RNA, and the mixture was incubated for 15 min at room temperature. After incubation, the mixture was treated with EDTA for 10 min at 65°C and then with proteinase K for 10 min at 65°C. RNA was purified with phenol and chloroform and then precipitated with ethanol. The RNA obtained was used to synthesize cDNA with oligo(dT) primers, one-twentieth of which was used for one PCR reaction. The DNA amplification was performed in a final volume of 30 l. PCR cycling conditions were 94°C for 2 min, followed by 30 cycles of 94°C for 15 s, 57°C for 30 s, and 72°C for 45 s, with a final step of 72°C for 7 min. Amplified product (15 l) was separated using electrophoresis in a 2% agarose gel and visualized with ethidium bromide. We analyzed transcripts of ␣1-, ␣2-, and ␤-subunits of mouse H ϩ ,K ϩ -ATPase by primer pairs as following: the upstream primer 1F (5Ј-CTTCAGGAACAAGATCCTGGTGA-3Ј) and the downstream primer 1R (5Ј-GAAGGATAGATTCCCTCCAATGG-3Ј) for ␣1, 2F (5Ј-CTTTGTTGCCATCATGGTCC-3Ј) and 2R (5Ј-GTATGCTTCA-CACAGTTTTC-3Ј) for ␣2, and 3F (5Ј-CTTCAACAACCCCCAT-GACCC-3Ј) and 3R (5Ј-AGGACGGGCAAATGATCACAG-3Ј) for ␤.
Immunohistochemistry. All of the cochlear samples for immunohistochemistry were prepared as described previously (24) . Viable dominant spotting (W v /W v ) mice were purchased from SLC (Hamamatsu, Japan). Briefly, deeply anesthetized mice were perfused from their left ventricle with 4% paraformaldehyde-0.1 M sodium phosphate, pH 7.4, and cochleas were isolated. The cochleas were decalcified in EDTA solution (0.12% EDTA in PBS, pH 7.4) for 5 days.
An affinity-purified rabbit polyclonal antibody against gastric H ϩ ,K ϩ -ATPase ␣1-subunit was kindly provided by Dr. Noriaki Takeguchi (Toyama Medical and Pharmaceutical University) (2) . The immunohistochemistry was performed as reported previously (26, 32) . The cochlear cryosections (12 m) were incubated with anti-␣ 1-subunit antibody (1:2,000 dilution) and fluorescein isothiocyanate (FITC)-labeled anti-rabbit antibody. Nuclei were detected using antiheterochromatin 1␥ (HP1␥) antibody (Chemicon, Temecula, CA) with Texas red (TXR)-labeled secondary antibody. The samples were examined under a confocal microscope (LSM 510; Carl Zeiss, Jena, Germany). We analyzed the expression of the ␣ 1-subunit in cochlea of adult male rats and guinea pigs using the same procedure.
Isolation of cells from stria vascularis and cellular immunolabeling. The temporal bones of anesthetized mice were removed, and the stria vascularis was dissociated. Tissue strips of stria vascularis were incubated for 30 min at 25°C in a normal Tyrode solution (136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2, 0.53 mM MgCl2, 5.5 mM glucose, and 5.0 mM HEPES-NaOH buffer, pH 7.4) containing 0.2% trypsin and then disrupted mechanically with pipetting (82) .
Anti-barttin antibody, which was raised in chicken and affinity purified, was kindly provided by Drs. Shinichi Uchida and Sei Sasaki (Tokyo Medical and Dental University). Immunolabeling was performed using the same protocol as the slice immunohistochemistry described in Immunohistochemistry. The isolated cells were treated with anti-barttin (1:100 dilution), anti-␣ 1-subunit (1:2,000 dilution), and anti-Kir4.1 (1:2,000 dilution) antibodies and then visualized with FITC-or TXR-labeled secondary antibodies (see Fig. 3 ).
Immunoelectron microscopic examination. Preembedding immunoelectron microscopic analysis was performed as described previously (22, 26) . Because the pigmentation in intermediate cells of C57 Black6 mice could be confused with immunoreactivity, we examined adult male ddY albino mice for this experiment. Anti-␣ 1-subunit antibody (1:100 dilution) was used to examine thin sections (thickness ϳ75-90 nm) of mouse cochlear lateral wall including the stria vascularis. The resulting immunoreactivity was visualized using the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) and 3,3Ј-diaminobenzidine.
Measurement of EP. Albino guinea pigs weighing 250 -300 g were treated with pentobarbital sodium (50 mg/kg im) and vecuronium bromide (1.0 mg/kg im) and artificially ventilated with room air. The cochlea was exposed using a ventrolateral approach. We inserted a glass microelectrode filled with 150 mM KCl solution into the scala media of the second turn through the spiral ligament. EP was measured with an electrometer amplifier (FD223; WPI, Sarasota, FL). An Ag-AgCl wire placed in the thigh muscle served as reference. The recording system was zeroed with the electrode in the perilymph of spiral ligament before insertion into the scala media. Vascular perfusion of the stria vascularis was performed at a rate of 1.5 ml/min until the reaction became a plateau (ϳ8 -10 min) through a polyethylene tube located in the vertebral artery at the same side of the cochlea. Perilymphatic perfusion of the scala tympani was performed at a rate of 10 l/min through a perfusion pipette connected to a syringe pump (UltraMicroPump II; WPI). The tip of the perfusion pipette was inserted into a small fenestration that was made in the bony wall of the scala tympani in the basal turn. The outlet for the perfusate was made at the top of the first turn. The artificial perilymph contained 126.0 mM NaCl, 5.0 mM KCl, 1.2 mM CaCl 2, 1.0 mM MgCl2, 24 mM NaHCO3, 0.5 mM NaH2PO4, 4.0 mM glucose, and 5 mM HEPESNaOH buffer (34) . Omeprazole (AstraZeneca, Osaka, Japan) was dissolved in control normal Tyrode solution or control artificial perilymph. The solution containing omeprazole, which is strongly alkaline, was adjusted to neutrality before its perfusion. Sch-28080 (Sigma, St. Louis, MO) was dissolved in methanol and stored at Ϫ20°C. Just before application, Sch-28080 was diluted in the control solutions, which also contained PUREBRIGHT MB-37 (10 mg/ml; Nippon Yushi, Tokyo, Japan). PUREBRIGHT MB-37 is a polymertype solubilizer that is reported to be of low toxicity (44) . The final concentration of methanol was Ͻ2%. The perfusion of either control Tyrode or artificial perilymph containing 2% methanol and 10 mg/ml PUREBRIGHT had no effect on EP (data not shown). . To examine which subunits were expressed in cochlea, we performed RT-PCR analyses of total RNAs obtained from mouse whole cochlea, kidney, and colon with the primers specific for each subunit (Fig. 1) .
RESULTS
Expression of gastric type H
Each set of the primers amplified a clear band when the total RNA of kidney or colon was used as a template (Fig. 1, lane  1) . Using the same primers, we found that cochlea clearly expressed the mRNAs of ␣ 1 -and ␤-subunits (lane 3). On the other hand, the ␣ 2 transcript was not detected in cochlear RNA (lane 3). The band of ␣ 2 was not visible even when the PCR products were stained with SYBR Green I, which is ϳ25 times more sensitive than ethidium bromide to detect DNA (data not shown). All of the fragments depicted in Fig. 1 (2) and analyzed it on a confocal microscope (Fig. 2) . The efficacy of this antibody was proven by specific and intense labeling of parietal cells in stomach (Supplemental Fig. 1 ), 1 as has been previously reported with other antibodies against ␣ 1 -or ␤-subunits of gastric H ϩ ,K ϩ -ATPase (16, 20) . We first examined the labeling in mouse cochlea at low magnification. The antibody clearly labeled specific components of cochlear lateral wall ( Fig. 2A, green) . A moderate signal was detected in spiral ganglions as well ( Fig. 2A ). In the lateral wall, we observed strong ␣ 1 immunolabeling in the lower part of spiral ligament, where type II and IV fibrocytes dominate, and also in stria vascularis, as reported previously (49) . In addition, we detected clear labeling in the suprastrial zone and spiral limbus, where type V and another type of fibrocyte are respectively distributed ( Fig. 2A) . The regions with types I and III fibrocytes were free from labeling ( Fig.  2A) . A similar expression pattern for the ␣-subunit was also observed in cochleae of rats and guinea pigs (Supplemental Fig. 2) . All of the reactions were specific, because no immunolabeling was detected when the antibody preincubated with excess immunized oligopeptide was used (data not shown). There was a faint signal in the tectrial membrane, which often shows nonspecific reactions (12, 64).
Fig. 1. RT-PCR analysis of H
ϩ ,K ϩ -ATPase subunits in mouse cochlea. Sets of primers specific for ␣1-, ␣2-, and ␤-subunits of H ϩ ,K ϩ -ATPase were used for PCR reactions as indicated. Total RNAs obtained from kidney, colon, and cochlea were treated with (lanes 1 and 3) or without (lanes 2 and 4) RT and then amplified with the specific primers. PCR products were stained with ethidium bromide.
Fig. 2. Expression and distribution of H
ϩ ,K ϩ -ATPase ␣1-subunit in mouse cochlea. Mouse cochlear sections were treated with an antibody specific to the ␣1-subunit, and the immunoreactivity was visualized using FITC-conjugated secondary antibody. Images were obtained with a confocal microscope. A: low-magnification image. The ␣1-subunit (green) was expressed in stria vascularis (StV), the lower portion of spiral ligament containing types II and IV fibrocytes, the suprastrial zone (SSZ) comprising type V fibrocytes, and spiral limbus (Lim). Moderate labeling also was detected in spiral ganglions (SG). Note that no signal was detectable in outer sulcus cells (OSC) or in the region of type I and III fibrocytes (arrowheads). SV, scala vestibuli; SM, scala media; ST, scala tympani; TM, tectrial membrane. Roman numerals indicate fibrocyte types. B-D: higher magnification images from different regions of the cochlea. In the lower part of the ligament (B), OSC and endothelial cells of blood vessels (V) were found to be free from ␣1 labeling, indicating that the subunit was certainly expressed in the fibrocytes. The outline of the OSC is indicated by the white line (B). In stria vascularis, ␣1 immunoreactivity was observed in the middle part, but at neither the apical side of marginal cells (arrows) nor in the basal cell (BC) layer (C, arrowheads). Moderate labeling also was visible in the cytosol of ganglion neurons (GC) but not in satellite cells (SC) (D). These sections also were stained with anti-heterochromatin 1␥ antibody (red) to visualize the nuclei (B-D) (25) .
We then examined the distribution of the ␣ 1 -subunit in spiral ligament and stria vascularis at a higher magnification. In the ligament, careful observation identified the "dot"-like labeling around ovoid or round nuclei that is associated with fibrocytes ( Fig. 2B) (71) . Labeling was not detected in either endothelial cells around blood vessels or outer sulcus cells (Fig. 2B) . We therefore concluded that the ␣ 1 -subunit was expressed specifically in the fibrocytes of this region, i.e., types II and IV.
In stria vascularis, a strong signal was diffusely detected in its middle part, where basolateral membranes of marginal cells and apical membranes of intermediate cells are localized (Fig.  2C) . No labeling was visible at either the apical site of marginal cells (arrows) or in the basal cell layer (arrowheads). As in the spiral ligament, we could not detect any ␣ 1 immunoreactivity in endothelial cells in stria vascularis (Fig. 2C) . These results strongly suggest that the ␣ 1 -subunit is localized at either the basolateral membrane of marginal cells or the apical site of intermediate cells. The resolution of confocal microscopic analysis was, however, insufficient to precisely determine the localization of the ␣ 1 -subunit, because the basolateral membrane of marginal cells and the apical membrane of intermediate cells are associated in close vicinity of ϳ150 -200 Å and are prominently invaginated (28, 72) . In spiral ganglions, we detected moderate labeling of the ␣ 1 -subunit in the neurons but not in satellite cells (Fig. 2D) .
The RT-PCR study revealed that the cochlea expressed mRNA of the ␤-subunit of the H ϩ ,K ϩ -ATPase (see Fig. 1 ). However, we could not detect any immunolabeling with commercially available anti-␤-subunit antibodies. This may be due to either very low protein expression level of the ␤ subunit in cochlea or loss of its antigenicity during the decalcification treatment (see MATERIALS Fig. 2 ), we still detected clear ␣ 1 immunoreactivity in the stria vascularis of this mutant mouse (Supplemental Fig. 3, A  and B) , whereas the immunoreactivity of Kir4.1, which locates in intermediate cells, disappeared completely (Supplemental Fig. 3C ). This observation suggests that the H ϩ ,K (Fig. 3) .
Morphologically, marginal cells can be identified with their highly convoluted and infolded basolateral membrane (72) . We also visualized barttin immunoreactivity as another hallmark for marginal cells (15) . The barttin-immunopositive cells (Fig.  3A, green) possessed a highly convoluted and infolded basolateral membrane (arrowheads), ensuring that they were mar- ginal cells. These cells were labeled with the anti-␣ 1 -subunit antibody (Fig. 3A, red) . Notably, labeling was detected at the basolateral side (arrowheads) but not at the apical membrane (arrows), of the marginal cells (Fig. 3A) . Intermediate cells are a type of melanocytes (27, 82) . Thus isolated intermediated cells could be identified with the melanin pigments. The cells with black pigments were devoid of either ␣ 1 or barttin immunoreactivity (Fig. 3B, top) , although they were clearly labeled with anti-Kir4.1 antibody (Fig. 3B, bottom, red) (1, 23) . These results suggest that the H ϩ ,K ϩ -ATPase is expressed in marginal but not in intermediate cells.
Finally, we conducted an immunoelectron microscopic examination on mouse stria vascularis (Fig. 4) . Because it is often difficult in colored animals like C57 Black6 mice to distinguish the positive signal (black) of immunoreactivity from the pigmented inclusion bodies of intermediate cells, we examined the cochlea of albino ddY mice for this experiment. Marginal cells project their abundant basolateral processes to endothelial cells and pericytes of blood vessels (Fig. 4A) . We detected prominent labeling of anti-␣ 1 antibody at the invaginated basolateral membrane of marginal cells (Fig. 4, A and B, asterisks) . Little signal was visible on the apical site of these cells (Fig. 4A,  arrows) . Endothelial cells and pericytes were free from staining (Fig. 4B) . We also carefully examined intermediate cells and their surroundings. The ␣ 1 -immunopositive infoldings of basolateral membrane of marginal cells (Fig. 4C, asterisks) tightly wrapped the soma and the processes of intermediate cells. The highly magnified images confirmed that the immunoreactivity was detected at the basolateral site of marginal cells (Fig. 4, D and E, asterisks) but not either on the somatic membrane (Fig. 4D, arrowheads) or at the projections (Fig. 4E,  arrowheads) Fig.  2A ) was found to be very similar to that of Na ϩ ,K ϩ -ATPase and NKCC1 (11, 18, 36, 57, 67 ). This suggests that the H ϩ ,K ϩ -ATPase may also be involved in cochlear K ϩ circulation. To examine this possibility, we applied a specific inhibitor of gastric type H ϩ ,K ϩ -ATPase, Sch-28080, to spiral ligament and also to stria vascularis. We used guinea pigs in this experiment, because this preparation is more suitable for electrophysiological measurement of EP. The expression of the ␣ 1 -subunit in guinea pig cochlea was confirmed with immunolabeling (Supplemental Fig. 2) .
We first perfused the drug into perilymph to examine the role of the H ϩ ,K ϩ -ATPase in the cochlear spiral ligament (Fig.  5) . Sch-28080 decreased EP in a dose-dependent fashion (Fig.  5D ). Sch-28080 (300 M) dramatically decreased EP from ϩ81.3 to ϩ34.0 mV in 15 min in the example shown in Fig.  5A . Upon washout of the blocker, EP gradually returned to the initial level, indicating that its inhibitory effect is reversible (Fig. 5A) . Sch-28080 (1 mM) suppressed EP more strongly, and the potential reached a negative value of Ϫ9.2 mV (Fig.  5B) . These results suggest that the H ϩ ,K ϩ -ATPase in spiral ligament is involved in formation of EP. On the other hand, perfusion of the perilymph with a high concentration of omeprazole (5 mM), an irreversible inhibitor of gastric H ϩ ,K ϩ -ATPase that is active only in an acidic environment (ϽpH 5) (51, 89), had little effect on EP ( Fig. 5C; n ϭ 4) . This may suggest that the extracellular fluid surrounding the strial H ϩ ,K ϩ -ATPase is not acidic enough to activate the drug. To examine the physiological function of the H ϩ ,K ϩ -ATPase in stria vascularis, we applied Sch-28080 to a vertebral artery (Fig. 6) , where the perfusate reaches the "intrastrial space" (see DISCUSSION) , which is surrounded by the basolateral membrane of marginal cells and the apical membrane of intermediate cells (53) . As reported previously (24, 53, 81) , vascular perfusion of 
Ba
2ϩ (300 M), a blocker of inwardly rectifying K ϩ (Kir) channels, quickly suppressed EP (Fig. 6A) . Sch-28080 (1 mM) strongly reduced the potential (Fig. 6A) . A higher concentration (3 mM) of the drug completely suppressed EP (Fig. 6A) . EP under administration into vertebral artery of Sch-28080 at 1 and 3 mM was ϩ26.2 Ϯ 7.4 mV (n ϭ 5) and Ϫ7.7 Ϯ 9.3 mV (n ϭ 3), respectively (control: ϩ75.8 Ϯ 1.9 mV; n ϭ 7) (Fig.  6C) . Under the same conditions, the perfusion of up to 10 mM omeprazole had little effect on EP ( Fig. 6B; n ϭ 3) . These results suggest that the gastric H ϩ ,K ϩ -ATPase expressed in both spiral ligament and stria vascularis is functionally important in generation of the EP.
DISCUSSION
The major findings in this study are as follows. 1) In the cochlear lateral wall, the gastric type but not the colonic type of H Specificity of Sch-28080 in inhibition of EP Sch-28080 is an inhibitor specific to gastric H ϩ ,K ϩ -ATPase. In in vitro experiments using the vesicles isolated from stomach, gastric glands, and the human embryonic kidney (HEK) cells exogenously expressing ␣ 1 -and ␤-subunits of the gastric H ϩ ,K ϩ -ATPase, it was reported that the IC 50 value of the drug to inhibit the ATPase is ϳ0.2-5.2 M and that ϳ100 M of Sch-28080 is enough for complete inhibition (3, 85, 88) . It was shown that at this concentration, the drug did not affect the activity of other transporters such as Na ϩ ,K ϩ -ATPase and NKCC1 (4, 5, 7, 50, 68, 85, 92) . In this study, we needed to perfuse 1 or 3 mM of Sch-28080 to the perilymph or the vertebral artery, respectively, to achieve complete suppression of EP (Figs. 5 and 6). It is therefore possible that the application of such high concentrations of Sch-28080 affected ion transport apparatuses other than H ϩ ,K ϩ -ATPase and thus suppressed EP. Measurement of the actual concentration of Sch-28080 at the sites of action in cochlear lateral wall may be needed to reach the final conclusion whether the drug action is specific to inhibition of the H ϩ ,K ϩ -ATPase. At present, however, it is technically very difficult to achieve this task, because the volume of the extracellular solution surrounded with invaginated basolateral membrane of marginal cells and that of the perilymph around infolded processes of the fibrocytes are very small (28, (71) (72) (73) .
Nevertheless, on the basis of the relationship between the in vitro properties of other inhibitors and their effects on EP, we can roughly estimate the concentration of Sch-28080 in the lateral wall of living animals. For example, it was shown that total suppression of EP by inhibiting NKCC1 at the basolateral site of marginal cells or in the fibrocytes of the ligament required 1 mM of furosemide when applied through vertebral artery or perilymph (42, 47, 69) , whereas 100 M of furosemide was enough to completely inhibit the NKCC1 itself with the IC 50 value of ϳ2.5-3.0 M (66, 77) . Thus the drugs in the perfusates are expected to be diluted to ϳ1/10 at the site of action in cochlea. Therefore, it would be the case that the actual concentration of Sch-28080 reaching the marginal cells in the stria or the fibrocytes in the ligament may be on the order ] IS ) of ϳ1-2 mM and exhibits a highly positive potential of approximately ϩ100 mV with reference to the body fluid (Fig. 7B) (31, 65) . IS is electrically isolated with two tight-junction shields: the marginal cell layer and the basal cell layer (19, 33, 39, 40, 78) . Intermediate and basal cells are connected through gap junctions not only to each other but also to fibrocytes, endothelial cells, and pericytes (38, 80) . Thus all of these cells form an electrical syncytium, which is called the connective tissue gap-junction network (Fig. 7B) (38, 80) . The membrane potential (E m ) of the syncytium relative to the perilymph is Ϫ5-0 mV (31, 55, 65 ] was quite similar to the dependence of EP decline on [Ba 2ϩ ] that was perfused into the artery (81) . The E m of intermediate cells may therefore directly reflect the high potential of IS and this potential as a source of EP. It is also strongly suggested that Kir4.1 is responsible for formation of the potential difference across the apical membrane of intermediate cell. This idea is also supported by the observation that Kir4.1-null mice completely lost EP (54) . If Kir4.1 is the key player for establishment of the high potential of IS, the low [K ϩ ] IS (1-2 mM) must be constantly maintained to form the potential difference (65, 81, 91) . The NKCC1 and Na (28, 72 However, this may not be enough to explain why strong inhibition of any one of the H ϩ ,K ϩ -ATPase, the NKCC1, and the Na ϩ ,K ϩ -ATPase expressed in stria vascularis caused complete suppression of EP (Fig. 6) (46, 47) . One possibility might be that, at the basolateral site of marginal cells, the three apparatuses are functionally coupled to form a complex of machinery for effective K ϩ transport, and that disruption of any one of them would significantly impair K ϩ transport function of the complex. Further studies are needed to clarify this possibility. ] and thus EP. Two functional components are considered to be critically involved in the K ϩ circulation. They are the epithelial tissue and connective tissue gap junction networks (Fig. 7A) . The former is composed of the supporting cells beneath the hair cells, the epithelial cells on basilar membrane, and the outer sulcus cells, whereas the latter comprises the fibrocytes in spiral ligament and some cells in stria vascularis, as stated above. K ϩ released from the hair cells seems to be absorbed by the supporting cells and then transported to the stria vascularis via the two gap junction networks. There is no gap-junctional connection between the two networks. The type II and V fibrocytes contacting with the outer sulcus cells should therefore take up K ϩ by an active process for the K ϩ circulation. The NKCC1 and the Na ϩ ,K ϩ -ATPase in the fibrocytes may contribute to this process (37) . Perilymphatic perfusion of K ϩ -free solution, which may remove the extracellular K ϩ around the NKCC1 and the Na ϩ ,K ϩ -ATPase and thus cause them to dysfunction, and that of the inhibitors for these K ϩ uptake apparatuses dramatically reduce EP (52) . This highlights a possible involvement of polarized K ϩ transport via the fibrocytes in EP formation. In the present study we have shown that these particular fibrocytes also express the gastric type of the H ϩ ,K ϩ -ATPase (Fig.  2, A and B) and that a specific blocker for this pump, Sch-28080, applied to perilymph, caused suppression of EP (Fig. 5,  A and B) . Therefore, it may be reasonable to suggest that the H ϩ ,K ϩ -ATPase in the fibrocytes is also involved in K ϩ transport in the ligament and thus generation of EP. The H ϩ ,K ϩ -ATPase would accelerate cochlear K ϩ circulation by taking up K ϩ in exchange to H ϩ from perilymph alongside of the NKCC1 and the Na ϩ ,K ϩ -ATPase (Fig. 7B) . This also may occur in fibrocytes in the suprastrial zone of the spiral ligament and in those of the spiral limbus, which are thought to be another pathway of K ϩ transport from endolymph to perilymph (90 (Figs. 5 and 6 ). This observation may suggest that the extracellular solution in IS or in the ligament may not be acidic enough, because omeprazole is activated only in a strong acidic environment of pH Ͻ5 (51, 89). Actually, it has been reported that pH of perilymph is 7.8 -8.0 (56) . This may be due to the effective neutralization of the protons by HCO 3 Ϫ secreted via Cl Ϫ /HCO 3 Ϫ exchangers expressed in the outer sulcus cells neighboring the fibrocytes (75) . Although the pH value of IS solution has not yet been measured, the following observations in other tissues may support the idea that the solution would not be strongly acidic. For example, in the prostate of mice, the secretions are mildly acidic with a pH value of ϳ6.4. The slight acidification is, however, caused by the colonic H ϩ ,K ϩ -ATPase expressed in the prostate epithelia, because the secretions are alkalinized to pH ϳ7 when the ␣ 2 -subunit-gene is ablated (60) . In kidney, although gastric type H ϩ ,K ϩ -ATPase is shown expressed in its epithelia and involved in the control of proton transport in vitro with omeprazole (17, 41) , in vivo application of the inhibitor to healthy human subjects did not affect their urinary pH (29, 58) . Accordingly, differently from the gastric mucosa, the primary role of H ϩ ,K ϩ -ATPase in these organs, and probably also in cochlea, would be the absorption of K ϩ from the extracellular fluid and the pH control of intracellular milieu rather than extracellular fluid.
However, there remains a possibility that abnormality in the proton production by the H 
